Waterloo, Walloon Region, Belgium
ROLE: My ambition is to help small - mid-scale – large companies to drive their business development opportunities by taking a leading role in creation and implement of marketing/commercialization strategies, tactics and/or critical commercial projects to build category-leading products, therapies and/or services. KNOWLEDGE: My expertise comes from broad, multi-years, hands on experience in multinational pharmaceutical industry (Novavax, Baxter, Pfizer, GSK, Sanofi, Wyeth) in commercialization, marketing, business management, leadership and project management roles at local, regional and global levels. That enables me to guide teams for building strategies that nurture sustainable top and bottom lines growth. PERSONALITY: Innovative, curious, self-starter, value driven, energetic, autonomous, perseverant, tremendous drive, assertive, flexible, people and culture sensitive, positive I can be contacted by phone at +32 474 911 971 or +48 573 267 955 or by e-mail at [email protected] KEY COMPETENCIES: General Management | Partnership and Alliance Management | Head of Marketing | Pharmaceutical Marketing | Marketing Excellence | Global Marketing | International Marketing | Regional Marketing | Local Marketing | Digital Marketing | Multichannel Marketing | Commercialization | Business Management | Project Management | Consultancy | Market Development | Product Launch and Life Cycle Management | Products Divestment and Integration | Market Access | Strategic & Innovative Thinking | Execution Excellence | Goal Orientation | Problem Solving | Decision Making | Interpersonal Skills | Patient centricity | Integrity | Cross-functional and Cross-cultural direct and remote leadership | Change Management | Delegation | Empowerment | People development. • Opened for relocation, commuting • Readiness to travel up to 50% • Fluent in English and Polish
Identify business potentials and go-to-market strategies for Novavax vaccines across Nordics, Benelux and Central Easter Europe regions. Establish, develop and manage strategic commercialization partnership alliances in those regions.
Identified best Go-To-Market strategy, built and implemented winning country strategic approach
Led key commercial projects across all business unites in EMEA region to transform customers service offering, increase profitability and simplify portfolio
• Led meningococcal vaccine (Nimenrix) global business and achieved 75% value growth since acquisition in 2015 • Designed, drove and completed Mencevax vaccine global discontinuation in 2 years (business transitioned to next generation vaccine with substantially higher profitability) • Led meningococcal vaccines franchise commercial transition and integration from GSK for Pfizer (nearly hundred countries in scope) • Rewarded with Vaccines President’s awards twice in 3 years.
• Led meningococcal vaccine (Nimenrix) global launch and achieved 50% value share in 3 years • Co-Led with limited cross-functional team meningococcal vaccines franchise business continuation globally (achieved 15% value growth vs previous year) while actively supporting divestment negotiation of this business
• Owned full P&L; led vaccines business unit with 10 active personnel in marketing, sales, access and public affairs. ∙ Led, together with the direct team, turned of declining vaccines business in 2010 back to double digit sustainable growth in 2011+ ∙ Secured long term public contracts for key vaccines in company portfolio and developed foundations for future public contracts for cervical cancers and pneumococcal vaccines • Led the Central Europe Flu vaccine network (13 countries); improved production capacity and profitability by shared pack introduction • Executive member of country management team & Central Europe Vaccines Commercial Board.
• Led Life Cycle Management of key vaccine brands; doubled this business value in 3 years • Launched 2 new flagship vaccines (achieved nearly exclusive share in rotavirus category in 2 years and 15% share in pneumococcal category in 1 year) • Led people development (senior and junior level marketers)
• Increasing seniority in brand management for adult vaccines and direct report leadership